Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 1.5. It has been cited 61 times, with 49 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.619
From this paper's citation signal
Citation Network Contribution
0.927
From 41 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 49 citers.
NIH
Grant: UM1 AI068634
NIH
Grant: UM1 AI068636
NIH
Grant: UM1 AI106701
National Institute of Mental Health
Grant: R01-MH-116695
Emory Center for AIDS Research
Grant: P30AI050409
NIAID NIH HHS
Grant: UM1 AI069496
NIMH NIH HHS
Grant: R01 MH116695
NIAID NIH HHS
Grant: K24 AI145806
NIAID
FWCI
10.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals